Marvellous Medicine
Analysis14 Jun 2021

Marvellous Medicine

Most of us were blindsided by the novel virus SarsCov2, but infectious disease experts had been warning about the possibility of a global pandemic for some years. For them it was never a matter of if, but when. What did come as a surprise was the speed of scientific progress to fight Covid 19. The first effective vaccine, from Pfizer/BioNTech, was developed in under 300 days, followed in successive weeks by Moderna and Oxford/AstraZeneca. The results of the UK’s RECOVERY trial, which was organised in a matter of weeks, has saved an estimated million lives worldwide by identifying which treatments are effective in treating Covid 19. And regulators around the globe, like Britain’s MHRA, are using innovative programmes to get medical products to people faster. During the pandemic, the world witnessed how fast medicine can advance with an abundance of cash and collaboration. Is progress at this speed and cost sustainable? Sandra Kanthal asks if drug development is something which should still take decades, or have we learned how to permanently accelerate the process?

Guests:

Rod MacKenzie, Chief Development Officer, Pfizer Nuala Murphy, President Clinical Research Services, Icon Professor Sir Martin Landray, Co-Chief Investigator, RECOVERY Trial Nicholas Jackson, Head of Programmes and Technology, CEPI Christian Schneider, Interim Chief Scientific Officer, MHRA Hilda Bastian, Independent Scientist

Producer and Presenter Sandra Kanthal Editor Jasper Corbett

Episoder(389)

Hospital Trust?

Hospital Trust?

Is public affection for the NHS preventing it from becoming fit for the future? Polling suggests that despite many complaints about the public health service, it is regarded as a much-loved and unique...

23 Jan 201728min

Brexit: What Europe Wants

Brexit: What Europe Wants

How political forces in other countries will shape any future UK-EU deal.As a younger man, Anand Menon spent a care-free summer Inter-railing around Europe. Some decades later, and now a professor of ...

14 Nov 201628min

How Did We Save the Ozone Layer?

How Did We Save the Ozone Layer?

On 30 June this year, a study was released in one of the world's top scientific journals. It explained how a group of scientists who had been measuring the amount of ozone in the stratosphere had made...

7 Nov 201628min

Trusting Inmates

Trusting Inmates

Should we place more trust in prisoners to help them change their lives? "Trust is the only thing that changes people," says Professor Alison Liebling, the director of the Prisons Research Centre at t...

31 Okt 201628min

The Myth of Mobs

The Myth of Mobs

In popular imagination, being in a crowd makes people scary and irrational. But is this true? In this edition of Analysis, David Edmonds asks social psychologists - including a leading expert on group...

24 Okt 201628min

Brexit and Northern Ireland

Brexit and Northern Ireland

Is the island of Ireland where Brexit will matter most? Edward Stourton visits Londonderry, right on the Irish border, to explore what's at stake as the UK leaves the EU. Some locals fear the border a...

17 Okt 201628min

Gentrification

Gentrification

Can the process of gentrification be controlled? It is often hailed as a sign of social and economic progress. Places which were originally poor and downtrodden are transformed into prosperous and vib...

10 Okt 201628min

Breaking Promises

Breaking Promises

Paul Johnson, director of the Institute of Fiscal Studies, asks if the time has come for the government to break pledges made to pensioners. He charts how the average income of senior citizens has ris...

3 Okt 201628min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden-usa
aftenpodden
stopp-verden
forklart
i-retten
popradet
det-store-bildet
fotballpodden-2
nokon-ma-ga
dine-penger-pengeradet
rss-gukild-johaug
bt-dokumentar-2
aftenbla-bla
hanna-de-heldige
rss-ness
frokostshowet-pa-p5
rss-penger-polser-og-politikk
rss-dannet-uten-piano
e24-podden